| Long-term effect of diabetes and its treatment on cognitive function TDERG Jacobson AM, Ryan CM, Cleary P, Waberski BH, Burwood A, Weinger K ... N Engl J Med 356, 1842-52, 2007 | 762* | 2007 |
| Neuropathy among the Diabetes Control and Complications Trial (DCCT) cohort 8 years after trial completion TDERG Martin CL, Albers J, Herman WH, Cleary P, Waberski BH, Greene DA ... Diabetes Care 29, 340-44, 2006 | 555 | 2006 |
| Use of the Michigan Neuropathy Screening Instrument (MNSI) as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and … TDERG Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW ... Diabetic Medicine 29, 937-44, 2012 | 496 | 2012 |
| Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of … TDERG Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA ... Diabetes Care 33, 1090-6, 2010 | 466 | 2010 |
| Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: The Diabetes Control and Complications Trial/Epidemiology … TDERG Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL ... Circulation 119, 2886-93, 2009 | 374 | 2009 |
| Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC cohort TDERG Chen Z, Miao F, Paterson AD, Lachin JM, Zhang L, Riggs AD, Schones D ... Proceedings of the National Academy of Sciences 113, E3002-11, 2016 | 210 | 2016 |
| Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the DCCT cohort TDERG Jacobson AM, Ryan CM, Cleary PS, Waberski BH, Weinger K, Musen G, Dahms W Diabetologia 54, 245-55, 2011 | 195* | 2011 |
| The long-term effects of type 1 diabetes treatment and complications on health-related quality-of-life: a 23 year follow-up of the Diabetes Control and Complications Trial … TDERG Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME Diabetes Care 36, 3131-8, 2013 | 188 | 2013 |
| DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history TDERG Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA ... Current Diabetes Report 10, 276-82, 2010 | 158 | 2010 |
| Musculoskeletal complications in type 1 diabetes TDERG Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J ... Diabetes Care 37, 1863-69, 2014 | 149 | 2014 |
| Risk factors for cardiovascular disease in type 1 diabetes TDERG Nathan DM, Bebu I, Braffett BH, Orchard TJ, Cowie CC, Lopes-Virella M ... Diabetes 65, 1370-9, 2016 | 147* | 2016 |
| Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial TDERG Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K ... Diabetes Care 31, 1933-38, 2008 | 141 | 2008 |
| Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions … BH Braffett, RA Gubitosi-Klug, JW Albers, EL Feldman, CL Martin, ... Diabetes 69 (5), 1000-1010, 2020 | 134 | 2020 |
| The risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT/EDIC study TDERG Gubitosi-Klug RA, Braffett BH, White N, Sherwin RS, Service JF, Lachin ... Diabetes Care 40, 1010-16, 2017 | 134 | 2017 |
| Extending the preoxygenation period from 4 to 8 mins in critically ill patients undergoing emergency intubation CJ Mort TC, Waberski BH Critical Care Medicine 37, 68-71, 2009 | 120 | 2009 |
| Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT … TDERG Pop-Busui R, Braffett BH, Zinman B, Martin C, White NH, Herman WH ... Diabetes Care 40, 94-100, 2017 | 116 | 2017 |
| Association between cardiovascular autonomic neuropathy and left ventricular dysfunction in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions … TDERG Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA ... Journal of the American College of Cardiology 61, 447-54, 2013 | 106* | 2013 |
| Vibration Perception Threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and Complications Trial … TDERG Martin CL, Waberski BH, Pop-Busui R, Cleary PA, Catton S, Albers JW ... Diabetes Care 33, 2635-41, 2010 | 105 | 2010 |
| Effect of excessive weight gain on cardiovascular outcomes in type 1 diabetes : results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions … TDERG Purnell JQ, Braffett BH, Zinman B, Gubitosi-Klug RA, Sivitz W, Bantle ... Diabetes Care 40, 1756-62, 2017 | 97 | 2017 |
| Risk factors for first and subsequent CVD events in type 1 diabetes: the DCCT/EDIC study I Bebu, D Schade, B Braffett, M Kosiborod, M Lopes-Virella, EZ Soliman, ... Diabetes Care 43 (4), 867-874, 2020 | 77 | 2020 |
